Get the Daily Brief
Latest Biotech News
Royalty Pharma Acquires Amgen’s Immunotherapy: $950 Million Deal
Royalty Pharma has secured a royalty interest in BeOne Medicines’ Imdelltra, an immunotherapy for extensive-stage small cell lung cancer, in a deal valued up to $950 million. Imdelltra, a...
AI Uncovers Antimicrobial Peptides in Venoms: A New Drug Source
Researchers from the University of Pennsylvania have employed artificial intelligence to identify novel antimicrobial compounds within venom proteins of snakes, spiders, and scorpions. These...
Pythia Model Advances Precision in CRISPR–Cas9 Genome Editing
A novel deep learning framework named Pythia promises to revolutionize precision gene editing by forecasting optimal repair templates for CRISPR–Cas9 applications. This method enhances editing...
Baxdrostat Phase 3 Filing Ahead After Hypertension Phase 3 Success
AstraZeneca’s candidate hypertension drug baxdrostat demonstrated approximately 10 mmHg blood pressure reductions in a pivotal phase 3 trial, setting the stage for imminent FDA submission. The...
Novel Therapeutics Targeting BTK and WEE1 in Cancer Treatment
Recent research introduces innovative compounds aimed at modulating Bruton’s tyrosine kinase (BTK) and WEE1 kinase, key regulators in cancer cell survival and proliferation. Shanghai Helioson...
Machine Learning Enhances Radiomics and Deep Learning for Cancer Prognosis
Innovative AI-driven methodologies are increasingly advancing oncology diagnostics and prognostics. Researchers have employed XGBoost models to differentiate primary brain tumors from metastases,...
Advances in Biomarkers and Cellular Mechanisms in Cancer and Reproductive Health
Recent studies have elucidated important molecular biomarkers and pathways impacting cancer and reproductive outcomes. Investigations highlight CBFA2T3 as a prognostic biomarker in lung...
Rapid Testing and AI in Healthcare: Fighting Resistance and Predicting Outcomes
The integration of rapid RT-PCR testing in outpatient settings emerges as a key tool in combating antibiotic resistance by reducing unnecessary prescriptions. Concurrently, AI innovations such as...
Innovations in Medical Devices and Monitoring Enhance Patient Care
Recent developments in biomedical engineering showcase milestones in device innovation, including handheld robotic-assisted guidance for ACL reconstruction, laser sensor technology for real-time...
Royalty Pharma Buys Amgen’s Lung Cancer Drug: $950 Million Deal
Royalty Pharma has acquired a royalty interest in Amgen’s immunotherapy Imdelltra, used for extensive-stage small cell lung cancer (ES-SCLC), in a deal worth up to $950 million. Imdelltra, a...
AI Reveals Antibiotic Candidates in Venoms: A New Fight Against Resistance
Researchers have leveraged artificial intelligence to explore the antimicrobial potential of peptides found in animal venoms, including snakes, spiders, and scorpions. Venoms, evolved over...
Breakthrough in CRISPR: Pythia Enhances Precision Genome Editing
The development of Pythia, a deep learning framework, marks a significant advancement in CRISPR–Cas9 genome engineering. It forecasts optimal repair templates enabling predictable and precise gene...
Alnylam’s Hypertension Drug Misses Endpoint but Advances to Phase 3
Alnylam Pharmaceuticals’ RNA interference therapy zilebesiran failed to significantly reduce blood pressure in a key Phase 2 trial involving high-risk patients already on standard hypertension...
SeeMe AI Detects Hidden Consciousness in Comatose Patients
Researchers at Stony Brook University developed SeeMe, an artificial intelligence system analyzing minute facial movements from video recordings to detect consciousness in patients clinically...
Fecal miR-92a Emerges as Biomarker for Colorectal Cancer Screening
A study led by Wang and colleagues has demonstrated the efficacy of fecal miR-92a as a non-invasive diagnostic biomarker for advanced colorectal neoplasia. As colorectal cancer rates rise...
Novel BTK Inhibitor Induces Apoptosis in Tumor Cells
Shukla, Sharma, and Gupta have identified a new Bruton’s Tyrosine Kinase (BTK) inhibitor demonstrating potent pro-apoptotic effects in cancer cells. BTK, central to B-cell receptor signaling, is a...
Advances in Exotic Organ Transplantation: Porcine Hearts to Humans
Kawamura and collaborators have reported significant progress in genetically modified pig-to-human cardiac xenotransplantation. This cutting-edge field aims to address the organ shortage crisis by...
Machine Learning Differentiates Brain Tumors from Metastases
Liu and coworkers have developed an XGBoost-based machine learning model employing radiomic features from brain MRI to distinguish primary brain tumors from lung cancer-derived brain metastases....
Exosomics Unveil Tumor Biology and Therapeutic Strategies
Li, Wang, Zhang, and colleagues detail groundbreaking progress in understanding tumor-derived exosomes, focusing on their roles in cancer pathogenesis, diagnosis, and treatment. This comprehensive...
Venom-Derived Antimicrobials... AI Unlocks Antibiotic Potential
Researchers are harnessing artificial intelligence to explore venom peptides from snakes, spiders, and scorpions as a novel source of antibiotics. Animal venoms, evolved over hundreds of millions...